412077000: Adrenal hormone agent (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2467529014 Adrenal hormone agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2473681016 Adrenal hormone agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3199501000005112 binyrehormonmiddel da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
binyrehormonmiddel	Is a	Adrenal hormone	false	Inferred relationship	Some
binyrehormonmiddel	Is a	Drug allergen	false	Inferred relationship	Some
binyrehormonmiddel	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Adrenal hormone (disposition)	false	Inferred relationship	Some
binyrehormonmiddel	Is a	Hormone	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
triamcinolonacetonid 40 mg/ml suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Triamcinolone acetonide 250 microgram/mL cutaneous cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
triamcinolonacetonid 40 mg injektionsvæske, suspension, ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
triamcinolonacetonid 100 µg spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely triamcinolone acetonide 5 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
triamcinolonacetonid 3 mg injektionsvæske, suspension, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
hydrocortisonacetat 30 mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
budesonid 0,25 mg/2 ml suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Budesonide 200mcg/spray powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
budesonid 32 µg næsespray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Budesonide 7g inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
budesonid 0,5 mg/2 ml suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Dexamethasone 4 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely dexamethasone 750 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
dexamethason 0,5 mg/5 ml eliksir	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Dexamethasone 1 mg/mL cutaneous solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
dexamethasonnatriumphosphat 1 mg/ml opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
dexamethason 10 mg/25 g	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
dexamethasonnatriumphosphat 0,1 mg/ml opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
prednisolonnatriumphosphat 1 % opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
prednisolonnatriumphosphat 5 mg/5 ml flydende	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
prednisolonnatriumphosphat 1/8 % opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Prednisolone sodium phosphate 6.7mg/5 mL solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Fluocinonide 500 microgram/g cutaneous gel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely fluocinonide 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Medrysone 10 mg/mL eye suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Desonide 500 microgram/mL cutaneous cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely desonide 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Desonide 500 microgram/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Amcinonide 1 mg/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Desoximetasone 500 microgram/mL cutaneous cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Desoximetasone 500 microgram/g cutaneous gel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
desoximetason 0,5 % gel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Desoximetasone 2.5 mg/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely desoximetasone 2.5 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Hydrocortisone 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
hydrocortison 100 mg/60 ml klysma	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely hydrocortisone 25 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely hydrocortisone probutate 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
hydrocortison 2 %	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely betamethasone 600 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 400 µg aerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 80 µg aerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely fludroxycortide 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Fludroxycortide 250 microgram/mL cutaneous cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Fludroxycortide 500 microgram/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Fludroxycortide 250 microgram/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Triamcinolone 4 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Triamcinolone 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Prednisone 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Prednisone 2.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Prednisone 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Prednisone 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 0,042 % spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Beclomethasone dipropionate 84mcg/spray spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Beclometasone dipropionate 84 microgram/actuation nasal spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Fluticasone propionate 9g spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
hydrocortisonacetat 0,5 %	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
methylprednisolonnatriumsuccinat 125 mg injektionsvæske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Triamcinolone acetonide 1 mg/mL cutaneous cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
triamcinolonacetonid 50 µg spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Flunisolide 0.025mg spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely halcinonide 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Halcinonide 1 mg/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
hydrocortisonacetat 2,5 % creme	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Fludrocortisone acetate 0.1mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
hydrocortisonnatriumsuccinat 1000 mg pulver	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
hydrocortisonnatriumsuccinat 100 mg hætteglas pulver	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
hydrocortisonnatriumsuccinat 500 mg pulver	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
hydrocortisonacetat 2,5 % lotion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
hydrocortisonnatriumsuccinat 250 mg hætteglas pulver	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely hydrocortisone 5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Hydrocortisone 10 mg/mL cutaneous lotion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Hydrocortisone 10 mg/mL eye solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
fluorometholon 0,1 % salve	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
betamethason 0,6 mg/5 ml syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release oral solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely fluorometholone 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Cortisone acetate 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
cortisonacetat 50 mg/ml injektionsvæske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 84 µg inhalationsaerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
beclometasondipropionat 42 µg spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter conventional release cutaneous shampoo (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Methylprednisolone acetate 40mg/mL suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Methylprednisolone acetate 40mg suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Methylprednisolone acetate 80mg/mL suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely hydrocortisone butyrate 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
dexamethasonnatriumphosphat 0,1 % opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Dexamethasone sodium phospha 0.05%	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
prednisolonacetat 25 mg/ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Prednisolone acetate 1.25 mg/mL eye suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
prednisolonacetat 25 mg/ml suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
prednisolonacetat 50 mg/ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Clobetasol propionate 500 microgram/g cutaneous foam	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some
Clobetasol propionate 500 microgram/g cutaneous gel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	binyrehormonmiddel	Inferred relationship	Some

Start Previous Page 7 of 9 Next End

Reference Sets

Concept inactivation indicator reference set

REPLACED BY association reference set (foundation metadata concept)

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2467529014	Adrenal hormone agent (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2473681016	Adrenal hormone agent	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3199501000005112	binyrehormonmiddel	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)